Skip to content

Acute Kidney Injury in Children Operated for Congenital Heart Disease

Acute Kidney Injury in Children Operated for Congenital Heart Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01316497
Enrollment
105
Registered
2011-03-16
Start date
2008-07-31
Completion date
2010-12-31
Last updated
2012-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

Acute kidney injury, Ischemic preconditioning, Congenital heart defects, Cardiac surgical procedures, Infant, Child

Brief summary

The purpose of this study was to investigate if repeated inflation of a blood pressure cuff applied around one leg causing mild ischemia (remote ischemic preconditioning) could protect children operated for congenital heart disease from developing acute kidney injury.

Detailed description

Remote ischemic preconditioning (RIPC) refers to an intervention of remote, brief ischemia which confers systemic protection against consequences of reperfusion injury in distant organs. RIPC has been shown to protect various organs during major surgeries. Our hypothesis was that RIPC could protect kidney function in children operated for complex congenital heart disease.

Interventions

PROCEDURERemote ischemic preconditioning (RIPC)

RIPC was performed by applying a blood pressure cuff around the child's leg. The cuff was inflated to 40 mmHg above the systolic pressure in 4 cycles of 5 minutes. Every cycle of ischemia was followed by 5 minutes of reperfusion. The first RIPC cycle started after anesthesia induction when invasive arterial blood pressure was monitored. Appropriate cuff size was used choosing between four sizes. For reproducibility RIPC was performed on the right leg with only a few exceptions, when the leg was used for invasive catheters.

PROCEDUREControl

The cuff was applied on the leg without inflation in the control group.

Sponsors

Aase and Ejnar Danielsens Foundation
CollaboratorOTHER
The Augustinus Foundation, Denmark.
CollaboratorOTHER
Direktør Kurt Bønnelycke and Hustru fru Grethe Bønnelyckes Foundation
CollaboratorUNKNOWN
Helen and Ejnar Bjørnows Foundation
CollaboratorUNKNOWN
Raimond and Dagmar Ringgård-Bohn's Foundation
CollaboratorOTHER
Grosserer L.F. Foghts Foundation
CollaboratorUNKNOWN
Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation
CollaboratorOTHER
The Dagmar Marshall Foundation
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 15 Years
Healthy volunteers
No

Inclusion criteria

* Children admitted for surgery for congenital heart disease

Exclusion criteria

* heart surgeries of low complexity such as closure of septal defects, aortico-pulmonary windows, establishment of glenn shunts, subaortic membrane resection, redirection of anomalous pulmonary veins, valvotomies, repair of pulmonary artery stenosis and surgeries without the use of extracorporeal circulation

Design outcomes

Primary

MeasureTime frameDescription
Acute kidney injuryUp to 4 daysCategorized according to the RIFLE criteria (22): R= risk= increased p-creatinine \* 1.5 and/or urine output \< 0.5 ml/kg/hour for 6 hours, I= injury= increased p-creatinine \* 2 and/or urine output \< 0.5 ml/kg/hour for 12 hours, F= failure= increased p-creatinine \* 3 or p-creatinine ≥ 350 µmol/L in the setting of an acute increase of at least 44 µmol/L and/or urine output \< 0.3 ml/kg/hour for 24 hours or anuria for 12 hours, L= complete loss of renal function for \> 4 weeks (need for dialysis for longer than 4 weeks), E= end-stage renal disease (need for dialysis for longer than 3 months).

Secondary

MeasureTime frameDescription
Inotropic Score (IS)Up to 3 daysThe highest postoperative daily dose (µg/kg//min) was used in the formula: IS = \[(dopamine + dobutamine) × 1\] + (milrinone × 10) + \[(epinephrine + norepinephrine) × 100\] to calculate the IS.
Reoperation during hospital stay90 days
Length of stay at the ICU90 days
Arterial blood pressureUp to 3 daysIncidence of postoperative low blood pressure (below the age-reference level)
Mortality90 daysIn-hospital mortality
Level of cystatin C in plasmaUp to 4 days
Level of Neutrophil Gelatinase-Associated Lipocalin in plasma and urineUp to 4 days
Length of hospital stay90 days

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026